NOVOSTE BETA-CATH SYSTEM
FDA premarket approval P000018/S033 · decided 2003-06-11
Approval details
- PMA number
- P000018
- Supplement
- S033
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- NOVOSTE BETA-CATH SYSTEM
- Generic name
- Intravascular radiation delivery system
- Applicant
- Best Vascular, Inc.
- Date received
- 2003-05-12
- Decision date
- 2003-06-11
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- MOU
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Norcross, GA
- Statement
- CONVERTING DEMONSTRATOR DEVICES TO COMMERCIALLY AVAILABLE DEVICES BY ADDING AN ANTIMICROBIAL FLUSH TO THE MANUFACTURING PROCESS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.